logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
Expert Opinion on Therapeutic Patents 封面图

Expert Opinion on Therapeutic Patents

IF4.6
论文数3029
被引数4317
期刊论文 3029
发表时间
delete
A patenting perspective of IKZF2 molecular glue degraders (2020-present)IKZF2分子胶降解剂的专利视角（2020-至今）
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-10-13
delete0
PREAI
deleteXuqing Zhang
delete分享
delete收藏
Progress with FAK inhibitors in the patent literature (2020-present)2020年至今专利文献中FAK抑制剂的进展
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-09-20
delete0
PREAI
deleteBing-Bing Chen; Rui-Peng Feng; Jin-Bo Niu; Jian Song; Yuan-Bo Cui; Sai-Yang Zhang
delete分享
delete收藏
Aurora kinase inhibitors: an updated patent review (2021–present)Aurora激酶抑制剂：2021年至今的专利综述更新
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-09-15
delete0
PREAI
deleteYao-Sheng Zhang; Hong-Yu Zhang; Junmin Zhang; Shi-Wu Chen
delete分享
delete收藏
Overcoming the blood–brain barrier for therapeutics targeting neurodegenerative diseases: a patent review (2020–present)克服血脑屏障以靶向治疗神经退行性疾病：一项专利综述（2020年至今）
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-08-31
delete0
PREAI
deleteDaowei Huang; Roujun Lu; Ruijing Tang; Jiarui Sun; Zhipei Sang
delete分享
delete收藏
Selective PARP1 inhibitors (2021–2025): patent landscape, structural evolution, and future therapeutic opportunities选择性PARP1抑制剂（2021–2025）：专利格局、结构演变及未来治疗机遇
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-08-24
delete0
PREAI
deleteJilong Duan; Yanjing Duan; Dongling Gu; Jia Yang; Fenghua Kang; Youchao Deng; Dongsheng Cao
delete分享
delete收藏
Helicase-primase inhibitors as next-generation anti-HSV agents: from current clinical status to structure–activity relationships and patent coverage解旋酶-引物酶抑制剂作为下一代抗HSV药物：从当前临床状态到构效关系及专利覆盖
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-08-05
delete0
PREAI
deleteChristian Gege; Gerald Kleymann
delete分享
delete收藏
T-type calcium channel blockers: a review of recent advances (2018–2025)T型钙通道阻滞剂：近期进展综述（2018–2025）
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-08-04
delete0
PREAI
deleteYasinalli Tamboli; Laurent Ferron; Gerald W. Zamponi
delete分享
delete收藏
Myeloperoxidase (MPO) inhibitors: an updated patent review (2020 - present)髓过氧化物酶（MPO）抑制剂：2020年至今的专利综述更新
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-07-30
delete0
PREAI
deleteZhiwei Meng; Dan Chen; Xingyu Yao; Feng Wang; Zhouling Xie
delete分享
delete收藏
A patent review of mutant-selective PI3Kα inhibitors for the treatment of different cancers (2021–2025)2021–2025年针对不同癌症的突变选择性PI3Kα抑制剂专利综述
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-07-30
delete0
PREAI
deleteHaixiang Qi; Jiayang Wen; Heng Xu
delete分享
delete收藏
New insights on anticancer glucocorticoid receptor modulators: a patent review (2020-present)关于抗癌糖皮质激素受体调节剂的新见解：一项专利综述（2020年至今）
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-06-19
delete0
PREAI
deleteMartina Franzin; Marianna Lucafò; Debora Curci; Giuliana Decorti; Gabriele Stocco
delete分享
delete收藏
An updated review of discoidin domain receptor 1 (DDR1) modulators (2020-present)DDR1（盘状结构域受体1）调节剂研究进展（2020年至今）
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-06-10
delete0
PREAI
deleteYunliang Zhang; Zhen Wang; Ke Ding
delete分享
delete收藏
An update on PDGFR inhibitors: a patent review (2020 - present)PDGFR抑制剂的最新进展：专利综述（2020年至今）
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-27
delete0
PREAI
deleteSisir Nandi; Sarfaraz Ahmed; Soubhik Barma; Rishita Dey; Asmita Samadder
delete分享
delete收藏
Recent advances in the discovery of PKMYT1-targeting drugs: a patent review (2021–2025)近年来PKMYT1靶向药物的发现进展：一项专利综述（2021–2025）
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-21
delete0
PREAI
deleteYazhou Wang; Chao Wang; Feng Ren; Alex Zhavoronkov; Xiao Ding
delete分享
delete收藏
PCSK9 inhibitors: an updated patent review 2024–2025PCSK9抑制剂：2024–2025年专利综述更新
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-21
delete0
PREAI
deleteEnrico Mario Alessandro Fassi; Marco Albani; Lorenza D’Adduzio; Erica Ginevra Milano; Carmen Lammi; Giovanni Grazioso
delete分享
delete收藏
An updated patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2020–2025)神经退行性疾病中组蛋白去乙酰化酶6抑制剂专利的更新综述（2020–2025）
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-20
delete0
PREAI
deleteSida Shen
delete分享
delete收藏
A patent review of LPAR1 antagonists (2010 – present)2010年至现在溶血磷脂酸受体1拮抗剂专利综述
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-17
delete0
PREAI
deleteJiaxing Zhao; Yuxing Li; Wangshan Zheng; Yang Liu; Yan Yang; Yan Leng; Shiyu Wei; Jun Lou; Xiaofei Shang; Deping Tang
delete分享
delete收藏
Small molecule agonists of Toll-like receptors 7 and 8: an updated patent review 2021 – 2025Toll样受体7和8的小分子激动剂：2021-2025年专利更新综述
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-15
delete0
PREAI
deleteAkash M. Patel; Natalia Chernyak; W. Michael Seganish
delete分享
delete收藏
A patent review of VEGFR-2 inhibitors: an update (2022 – present)VEGFR-2抑制剂的专利综述：更新（2022年至今）
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-04-26
delete0
PREAI
deleteThoraya A. Farghaly; Marwa F. Harras; Amani M. R. Alsaedi; Sami A. Al-Hussain; Nadia T. Al-Qurashi; Sayed M. Riyadh; Magdi E. A. Zaki; Shadia M. Hussein
delete分享
delete收藏
Activin receptor-like kinase 5 (ALK5) inhibitors: a patent review (2013-present)激活素受体样激酶5 (ALK5) 抑制剂：专利综述 (2013-现在)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-04-19
delete0
PREAI
deleteXin-Yi Huang; Chao-Qun Yu; Xin Wang; Zhen Guo; Cheng-Hua Jin
delete分享
delete收藏
A patent review of NLRP3 inhibitors for inflammatory diseases (2023-present)NLRP3抑制剂的炎症性疾病专利综述（2023-至今）
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-04-10
delete0
PREAI
deleteJannatun N. Namme; Yiming Xu; Elijah McClendon; Can Zhang; Shijun Zhang
delete分享
delete收藏